In his new role Sturge will reportto Stefan Oschmann, Member of Merck’s Executive Board and responsible forthe company’s pharmaceutical businesses.
Merck Appoints Simon Sturge as New Head of Biosimilars Unit
In his new role Sturge will reportto Stefan Oschmann, Member of Merck’s Executive Board and responsible forthe company’s pharmaceutical businesses.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
